Post-approval studies (Phase 4)Looking for participantsNCT06909565
What this trial is testing
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Who this might be right for
Percutaneous Coronary InterventionPeripheral Endovascular Intervention
Duke University 6,000